BrainScope Announces FDA Clearance of the First Handheld Medical Device for Assessment of the Full Spectrum of Traumatic Brain Injury

News Panel of multi-modal capabilities will aid physicians with the clinical diagnosis of head-injured patients. Company's first commercial product, Ahead 300, to be introduced in coming months. Contributed Author:  BrainScope Company, Inc. Topics:  Neurology